| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | VDX0F5H4FP |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Bronchopulmonary Dysplasia | 3 | D001997 | ClinicalTrials |
| Autistic Disorder | 2 | D001321 | ClinicalTrials |
| Cerebral Palsy | 2 | D002547 | ClinicalTrials |
| Brain Ischemia | 2 | D002545 | ClinicalTrials |
| Child Development Disorders, Pervasive | 1 | D002659 | ClinicalTrials |
| Ischemic Stroke | 1 | D000083242 | ClinicalTrials |
| Hypoplastic Left Heart Syndrome | 1 | D018636 | ClinicalTrials |
| Hearing Loss | 1 | D034381 | ClinicalTrials |
| Hernias, Diaphragmatic, Congenital | 1 | D065630 | ClinicalTrials |
| Brain Injuries | 1 | D001930 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594461 |
| FDA SRS | VDX0F5H4FP |
CONTENTS